Skip to main content
DNLI logo

DNLI

Denali Therapeutics Inc.
$26.69 +0.38 (+1.44%) At close · Jul 8
Market Cap
$4.24B
Shares
158,709,737

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 269
Total Value: $2,729,543,389
Total Shares: 142,157,299
Showing 1–100 of 280 holdings by value · page 1 of 3

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 270 13F filers
Top Holder
9.2%
Jun 2023 → Mar 2026 · range 8.6% – 13.7%
of institutional value
Top 5
33.0%
Jun 2023 → Mar 2026 · range 33.0% – 46.3%
of institutional value
Top 10
49.4%
Jun 2023 → Mar 2026 · range 49.4% – 65.1%
of institutional value
HHI
351
Jun 2023 → Mar 2026 · range 351 – 561
Broadly held
Showing 100 of 280
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1714899 CUSIP 24823R105 13F (30d) 7 filings 6 filers Visit website Investor relations